Afrasiabi Garekani Hadi, Faghihnia Torshizi Mona, Sadeghi Fatemeh
a Pharmaceutical Research Center, School of Pharmacy , Mashhad University of Medical Sciences , Mashhad , Iran .
b Department of Pharmaceutics, School of Pharmacy , Mashhad University of Medical Sciences , Mashhad , Iran , and.
Drug Dev Ind Pharm. 2015;41(10):1655-60. doi: 10.3109/03639045.2014.983929. Epub 2014 Nov 17.
Use of Surelease as a granulation liquid in preparation of granules and matrices of theophylline and ethylcellulose was evaluated.
Physical mixtures (at 1:1 or 1:1.5 drug:polymer) were granulated using water, Surelease or diluted Surelease as granulating liquid. The granule characteristics (shape, size, flow rate, mechanical properties, friability and release profile) were studied. Afterwards, matrices were manufactured and their crushing strengths, friability and release profiles were determined.
Granulation produced agglomerated particles with better flowability than physical mixtures. Change of granulation liquid from water to Surelease or diluted Surelease led to the marginal increase in size of granules at 1:1 drug:polymer, however, the flow rate and Carr's index were considerably improved. The hardness, elastic modulus, friability and rate of drug release were not affected by granulation liquid. Increase in polymer content resulted in reduction in size of granules, flow rate, elastic modulus and rate of drug release. However hardness of the granules was unaffected. Granulation process and granulation liquid did not affect the hardness, and dissolution rate of matrices at 1:1 drug:polymer, while the use of Surelease or diluted Surelease as a granulating liquid, increased the hardness and decreased drug release rate at 1:1.5 drug:polymer. Matrices prepared from Surelease or diluted Surelease showed similar characteristics.
Surelease is a suitable granulating liquid for preparation of ethylcellulose matrices especially when high amount of polymer is used and could not only improve the flow and compatibility of the granules, but also help in reducing the rate of drug release.
评估使用Surelease作为制粒液制备茶碱和乙基纤维素颗粒及基质的效果。
使用水、Surelease或稀释的Surelease作为制粒液,对物理混合物(药物与聚合物比例为1:1或1:1.5)进行制粒。研究颗粒特性(形状、大小、流速、机械性能、脆碎度和释放曲线)。之后,制备基质并测定其抗压强度、脆碎度和释放曲线。
制粒产生的团聚颗粒比物理混合物具有更好的流动性。制粒液从水改为Surelease或稀释的Surelease,在药物与聚合物比例为1:1时,颗粒大小略有增加,但流速和卡尔指数得到显著改善。颗粒的硬度、弹性模量、脆碎度和药物释放速率不受制粒液影响。聚合物含量增加导致颗粒大小、流速、弹性模量和药物释放速率降低。然而,颗粒的硬度不受影响。制粒工艺和制粒液对药物与聚合物比例为1:1时基质的硬度和溶解速率没有影响,而使用Surelease或稀释的Surelease作为制粒液,在药物与聚合物比例为1:1.5时,会增加硬度并降低药物释放速率。由Surelease或稀释的Surelease制备的基质表现出相似的特性。
Surelease是制备乙基纤维素基质的合适制粒液,特别是在使用大量聚合物时,它不仅可以改善颗粒的流动性和相容性,还有助于降低药物释放速率。